Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis

World J Gastroenterol. 2015 Jul 7;21(25):7683-708. doi: 10.3748/wjg.v21.i25.7683.

Abstract

Primary biliary cirrhosis (PBC) is a chronic progressive cholestatic granulomatous, and destructive inflammatory lesion of small intralobular and septal bile ducts, which is likely to be caused by an autoimmune mechanism with a the presence of serum antimitochondrial antibodies and a potential tendency to progress to cirrhosis. Despite the fact that the etiology of this disease has been unknown so far, there has been a considerable body of scientific evidence that can reveal the clinical and laboratory signs of PBC and the individual components of its pathogenesis and elaborate diagnostic criteria for the disease and its symptomatic therapy. Deficiencies in autoimmune tolerance are critical factors for the initiation and perpetuation of the disease. The purpose of this review is to summarize the data available in the literature and the author's findings on clinical and laboratory criteria for the diagnosis of PBC. This review describes the major clinical manifestations of the disease and the mechanisms of its development. It presents the immunological, biochemical, and morphological signs of PBC and their significance for its diagnosis. A great deal of novel scientific evidence for the problem of PBC has been accumulated. However, the inadequate efficiency of therapy for the disease lends impetus to the quest for its etiological factors and to further investigations of its pathogenetic mechanisms and, on this basis, to searches for new methods for its early diagnosis.

Keywords: Biochemical signs; Clinical criteria; Immunological signs; Laboratory criteria; Morphological signs; Primary biliary cirrhosis.

Publication types

  • Review

MeSH terms

  • Autoantibodies / blood
  • Biomarkers / blood
  • Biopsy
  • Blood Chemical Analysis
  • Diagnosis, Differential
  • Diagnostic Imaging
  • Disease Progression
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Humans
  • Liver Cirrhosis, Biliary / blood
  • Liver Cirrhosis, Biliary / diagnosis*
  • Liver Cirrhosis, Biliary / epidemiology
  • Liver Cirrhosis, Biliary / genetics
  • Liver Cirrhosis, Biliary / immunology
  • Liver Function Tests
  • Molecular Diagnostic Techniques
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors

Substances

  • Autoantibodies
  • Biomarkers
  • Genetic Markers